Mathematical modelling of the spatio-temporal response of cytotoxic T-lymphocytes to a solid tumour.
暂无分享,去创建一个
Mark A J Chaplain | Anastasios Matzavinos | M. Chaplain | A. Matzavinos | V. Kuznetsov | Vladimir A Kuznetsov | Anastasios Matzavinos
[1] M. Retsky,et al. Prospective computerized simulation of breast cancer: comparison of computer predictions with nine sets of biological and clinical data. , 1987, Cancer research.
[2] Jonathan A. Sherratt,et al. Oscillations and chaos behind predator–prey invasion: mathematical artifact or ecological reality? , 1997 .
[3] L. Chen,et al. Immune regulation of the L5178Y murine tumor-dormant state. II. Interferon-gamma requires tumor necrosis factor to restrain tumor cell growth in peritoneal cell cultures from tumor-dormant mice. , 1987, Journal of immunology.
[4] James P. Freyer,et al. Tumor growthin vivo and as multicellular spheroids compared by mathematical models , 1994, Bulletin of mathematical biology.
[5] R. Demicheli,et al. Tumour dormancy: findings and hypotheses from clinical research on breast cancer. , 2001, Seminars in cancer biology.
[6] H. Kiss,et al. The Transfer of Interleukin‐8 Across the Human Placenta Perfused In Vitro , 1996, Obstetrics and gynecology.
[7] V. Kuznetsov. A mathematical model for the interaction between cytotoxic T lymphocytes and tumour cells. Analysis of the growth, stabilization, and regression of a B-cell lymphoma in mice chimeric with respect to the major histocompatibility complex. , 1991, Biomedical science.
[8] J. Xiang,et al. Lymphotactin Expression by Engineered Myeloma Cells Drives Tumor Regression: Mediation by CD4+ and CD8+ T Cells and Neutrophils Expressing XCR1 Receptor1 , 2001, The Journal of Immunology.
[9] V. P. Zhivoglyadov,et al. Kinetic approach and estimation of the parameters of cellular interaction between the immunity system and a tumor. , 1993, Archivum immunologiae et therapiae experimentalis.
[10] D. Drasdo,et al. Individual-based approaches to birth and death in avascu1ar tumors , 2003 .
[11] P. Friedl,et al. T lymphocyte locomotion in a three-dimensional collagen matrix. Expression and function of cell adhesion molecules. , 1995, Journal of immunology.
[12] T. Whiteside,et al. T cell recognition of human tumors: implications for molecular immunotherapy of cancer. , 1993, Clinical immunology and immunopathology.
[13] G. Bard Ermentrout,et al. Transition fronts and localized structures in bistable reaction-diffusion equations , 1997 .
[14] J. Uhr,et al. Cancer dormancy: studies of the murine BCL1 lymphoma. , 1991, Cancer research.
[15] J. Aguirre Ghiso. Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo , 2002, Oncogene.
[16] M. Nowak,et al. Virus dynamics: Mathematical principles of immunology and virology , 2001 .
[17] Ying Wang,et al. IL-8 Reduced Tumorigenicity of Human Ovarian Cancer In Vivo Due to Neutrophil Infiltration1 , 2000, The Journal of Immunology.
[18] R. Puri,et al. Interleukin-4 and cancer therapy. , 1993, Cancer investigation.
[19] F. Shanahan,et al. The Fas counterattack: cancer as a site of immune privilege. , 1999, Immunology today.
[20] John A. Adam,et al. The dynamics of growth-factor-modified immune response to cancer growth: One dimensional models , 1993 .
[21] N. Breslow,et al. Latent carcinoma of prostate at autopsy in seven areas. Collaborative study organized by the International Agency for Research on Cancer, Lyons, France , 1977, International journal of cancer.
[22] M. Herlyn,et al. Insulin-like growth factor-I-induced migration of melanoma cells is mediated by interleukin-8 induction. , 2002, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[23] A. Mantovani,et al. The signal transduction pathway involved in the migration induced by a monocyte chemotactic cytokine. , 1991, Journal of immunology.
[24] B. Fenton,et al. Alteration of tumour response to radiation by interleukin-2 gene transfer , 2000, British Journal of Cancer.
[25] René Lefever,et al. Stability problems in cancer growth and nucleation , 1980 .
[26] Markus R. Owen,et al. MATHEMATICAL MODELLING OF MACROPHAGE DYNAMICS IN TUMOURS , 1999 .
[27] R. Sutherland. Cell and environment interactions in tumor microregions: the multicell spheroid model. , 1988, Science.
[28] S. Rosenberg,et al. Specific release of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-alpha, and IFN-gamma by human tumor-infiltrating lymphocytes after autologous tumor stimulation. , 1991, Journal of immunology.
[29] L. Holmberg,et al. Work on your theories! , 1996, Nature Medicine.
[30] J A Sherratt,et al. Pattern formation and spatiotemporal irregularity in a model for macrophage-tumour interactions. , 1997, Journal of theoretical biology.
[31] G. D. Knott,et al. Modeling tumor regrowth and immunotherapy , 2001 .
[32] M A Lewis,et al. Ecological chaos in the wake of invasion. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[33] E. Lord,et al. Assessment of in situ host immunity to syngeneic tumors utilizing the multicellular spheroid model. , 1984, Cellular immunology.
[34] R. D'Amato,et al. Persistence of microscopic human cancers in mice: alterations in the angiogenic balance accompanies loss of tumor dormancy , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[35] R T Prehn,et al. Stimulatory effects of immune reactions upon the growths of untransplanted tumors. , 1994, Cancer research.
[36] M. Cross,et al. Pattern formation outside of equilibrium , 1993 .
[37] Z Bajzer,et al. Analysis of growth of multicellular tumour spheroids by mathematical models , 1994, Cell proliferation.
[38] D. Loeffler,et al. In vivo localization of lymphocytes labelled with low concentrations of Hoechst 33342. , 1989, Journal of immunological methods.
[39] G. Naumov,et al. Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. , 2002, Cancer research.
[40] A. Perelson,et al. Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis. , 1994, Bulletin of mathematical biology.
[41] S. Rosenberg,et al. T-cell recognition of human melanoma antigens. , 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.
[42] G. Heppner,et al. Mechanisms of lymphocyte traffic in neoplasia. , 1986, Anticancer research.
[43] R. Puri,et al. Kinetic analysis of high affinity forms of interleukin (IL)-13 receptors: suppression of IL-13 binding by IL-2 receptor gamma chain. , 1999, Biophysical journal.
[44] J. Jääskeläinen,et al. Migration of recombinant IL-2-activated T and natural killer cells in the intercellular space of human H-2 glioma spheroids in vitro. A study on adhesion molecules involved. , 1992, Journal of immunology.
[45] C. T. Chan,et al. Characterization of three-dimensional tissue cultures using electrical impedance spectroscopy. , 1999, Biophysical journal.
[46] E. Lord,et al. Specific (EMT6) and non-specific (WEHI-164) cytolytic activity by host cells infiltrating tumour spheroids. , 1987, British Journal of Cancer.
[47] Mark A. J. Chaplain,et al. On Growth and Form: Spatio-temporal Pattern Formation in Biology , 2000 .
[48] T. Rothstein,et al. Guinea pig antiserum to mouse cytotoxic T lymphocytes and their precursors. , 1978, Journal of immunology.
[49] J. Uhr,et al. Dormancy in a model of murine B cell lymphoma. , 2001, Seminars in cancer biology.
[50] M. Bar‐eli. Role of Interleukin-8 in Tumor Growth and Metastasis of Human Melanoma , 1999, Pathobiology.
[51] Bard Ermentrout,et al. Simulating, analyzing, and animating dynamical systems - a guide to XPPAUT for researchers and students , 2002, Software, environments, tools.
[52] H. Macdonald,et al. The multicellular spheroid as a model tumor allograft. III. Morphological and kinetic analysis of spheroid infiltration and destruction. , 1980, Transplantation.
[53] K. Hicks,et al. Multicellular membranes as an in vitro model for extravascular diffusion in tumours. , 1996, The British journal of cancer. Supplement.
[54] R. Foà,et al. Gene transfer in tumor therapy. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.
[55] R. Sutherland,et al. Growth and cellular characteristics of multicell spheroids. , 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[56] R. Kobayashi,et al. Self-organized pulse generator , 1995 .
[57] G. Nardella,et al. The multicellular tumor spheroid model. II. Characterization of the primary allograft response in unsensitized mice. , 1980, Transplantation.
[58] E. Bröcker,et al. Inflammatory cell infiltrates in human melanoma at different stages of tumor progression , 1988, International journal of cancer.
[59] J. Folkman,et al. How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. , 1986, Cancer research.
[60] P. Newsholme,et al. Macrophage-mediated lysis of a beta-cell line, tumour necrosis factor-alpha release from bacillus Calmette-Guérin (BCG)-activated murine macrophages and interleukin-8 release from human monocytes are dependent on extracellular glutamine concentration and glutamine metabolism. , 1999, Clinical science.
[61] M. Chaplain,et al. Spatio-temporal dynamics of the immune system response to cancer , 1997 .
[62] R. Gatenby,et al. Models of tumor-host interaction as competing populations: implications for tumor biology and treatment. , 1995, Journal of theoretical biology.
[63] H. Nishiura,et al. Human CC chemokine liver-expressed chemokine/CCL16 is a functional ligand for CCR1, CCR2 and CCR5, and constitutively expressed by hepatocytes. , 2001, International immunology.
[64] J. Sherratt,et al. Cells behaving badly: a theoretical model for the Fas/FasL system in tumour immunology. , 2002, Mathematical biosciences.
[65] R. Weger,et al. Immune reactivity in SL2 lymphoma-bearing mice compared with SL2-immunized mice , 2004, Cancer Immunology, Immunotherapy.
[66] V. Schirrmacher. T-cell immunity in the induction and maintenance of a tumour dormant state. , 2001, Seminars in cancer biology.
[67] Rene Lefever,et al. On the Growth of Cellular Tissues Under Constant and Fluctuating Environmental Conditions , 1984 .
[68] J A Sherratt,et al. Modelling the macrophage invasion of tumours: effects on growth and composition. , 1998, IMA journal of mathematics applied in medicine and biology.
[69] S. Cox,et al. Modelling Macrophage Infiltration into Avascular Tumours , 2002 .
[70] R. Gatenby,et al. Application of competition theory to tumour growth: implications for tumour biology and treatment. , 1996, European journal of cancer.
[71] S. Cole,et al. Uptake kinetics of monoclonal antibodies by human malignant melanoma multicell spheroids. , 1988, Cancer research.
[72] P. Musiani,et al. Tumor Rejection and Immune Memory Elicited by Locally Released LEC Chemokine Are Associated with an Impressive Recruitment of APCs, Lymphocytes, and Granulocytes1 , 2000, The Journal of Immunology.
[73] K. Weinhold,et al. The tumor dormant state. , 1981, Advances in cancer research.
[74] W. Clark,et al. The biologic forms of malignant melanoma. , 1986, Human pathology.